199 related articles for article (PubMed ID: 37761837)
1. Application of the Yamanaka Transcription Factors
Aguirre M; Escobar M; Forero Amézquita S; Cubillos D; Rincón C; Vanegas P; Tarazona MP; Atuesta Escobar S; Blanco JC; Celis LG
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761837
[TBL] [Abstract][Full Text] [Related]
2. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth.
Villodre ES; Felipe KB; Oyama MZ; Oliveira FH; Lopez PLDC; Solari C; Sevlever G; Guberman A; Lenz G
Biochem Biophys Res Commun; 2019 Sep; 517(2):324-329. PubMed ID: 31353083
[TBL] [Abstract][Full Text] [Related]
4. The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4.
Piskacek M; Otasevic T; Repko M; Knight A
Stem Cell Rev Rep; 2021 Oct; 17(5):1934-1936. PubMed ID: 34342803
[No Abstract] [Full Text] [Related]
5. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
6. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
7. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
Qi H; Pei D
Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
[No Abstract] [Full Text] [Related]
8. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
10. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
11. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
Senís E; Mosteiro L; Grimm D; Abad M
Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
[TBL] [Abstract][Full Text] [Related]
12. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
13. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
14. Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.
Malak PN; Dannenmann B; Hirth A; Rothfuss OC; Schulze-Osthoff K
Cell Cycle; 2015; 14(23):3748-54. PubMed ID: 26654770
[TBL] [Abstract][Full Text] [Related]
15. [Induced pluripotent stem cells. A new resource in modern medicine].
Liebau S; Stockmann M; Illing A; Seufferlein T; Kleger A
Internist (Berl); 2014 Apr; 55(4):460-9. PubMed ID: 24553769
[TBL] [Abstract][Full Text] [Related]
16. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
17. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
18. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
19. Biological importance of OCT transcription factors in reprogramming and development.
Kim KP; Han DW; Kim J; Schöler HR
Exp Mol Med; 2021 Jun; 53(6):1018-1028. PubMed ID: 34117345
[TBL] [Abstract][Full Text] [Related]
20. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]